12/5
07:14 am
ppbt
Purple Biotech Announces Closing of $2.8 Million Registered Direct Offering of American Depositary Shares [Yahoo! Finance]
High
Report
Purple Biotech Announces Closing of $2.8 Million Registered Direct Offering of American Depositary Shares [Yahoo! Finance]
12/5
07:13 am
ppbt
Purple Biotech Announces Closing of $2.8 Million Registered Direct Offering of American Depositary Shares
High
Report
Purple Biotech Announces Closing of $2.8 Million Registered Direct Offering of American Depositary Shares
12/3
08:34 am
ppbt
Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares [Yahoo! Finance]
Medium
Report
Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares [Yahoo! Finance]
12/3
08:23 am
ppbt
Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares
Medium
Report
Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares
12/2
07:10 am
ppbt
Purple Biotech Reports Positive Final Results from Randomized Phase 2 Study of CM24 in Second Line Pancreatic Cancer [Yahoo! Finance]
High
Report
Purple Biotech Reports Positive Final Results from Randomized Phase 2 Study of CM24 in Second Line Pancreatic Cancer [Yahoo! Finance]
12/2
07:00 am
ppbt
Purple Biotech Reports Positive Final Results from Randomized Phase 2 Study of CM24 in Second Line Pancreatic Cancer
High
Report
Purple Biotech Reports Positive Final Results from Randomized Phase 2 Study of CM24 in Second Line Pancreatic Cancer
11/15
03:26 pm
ppbt
Purple Biotech Ltd (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $33.00 price target on the stock.
Low
Report
Purple Biotech Ltd (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $33.00 price target on the stock.
11/15
07:06 am
ppbt
Purple Biotech Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Low
Report
Purple Biotech Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
11/15
07:00 am
ppbt
Purple Biotech Reports Third Quarter 2024 Financial Results
Low
Report
Purple Biotech Reports Third Quarter 2024 Financial Results
11/4
07:50 am
ppbt
Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death
Medium
Report
Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death
10/25
07:20 am
ppbt
Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Medium
Report
Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
10/10
07:30 am
ppbt
Purple Biotech to Present Data for its Tri-Specific Antibody Platform—CAPTN-3—at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Medium
Report
Purple Biotech to Present Data for its Tri-Specific Antibody Platform—CAPTN-3—at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics